Report - Segunda línea en cáncer de páncreas: entre Oxaliplatino y Nal-Iri · 2017. 6. 27. · 1. Ohkawa S, et al. Br J Cancer 2015;112:1428 2. Oettle H, et al. J Clin Oncol 2014;32:2423

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form